CTOs on the Move


 
Incorporated in 1994 as a certified Minority Business Enterprise, DISYS is one of the largest IT staffing firms in the US according to a report by Staffing Industry Analysts. DISYS is headquartered in McLean, Virginia, with offices and delivery locations worldwide in North and South America, Europe, and the Asia Pacific region.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million
  • www.disys.com
  • 8270 Greensboro Dr Ste 1000
    Mc Lean, VA USA 22102
  • Phone: 703.752.7900

Executives

Name Title Contact Details

Similar Companies

Direct Access Marketing Services

Direct Access Marketing Services is a Syosset, NY-based company in the Business Services sector.

Abc Fire

Abc Fire is a North Royalton, OH-based company in the Business Services sector.

Vitronics Soltec

Vitronics Soltec is a Hampton, NH-based company in the Business Services sector.

Modus Associates

Modus Associates is a New York, NY-based company in the Business Services sector.

Petauri

Petauri is a pharmaceutical services platform founded in 2023 and based in Nashville, Tennessee. The company focuses on providing integrated commercialization solutions for life sciences companies throughout the therapeutic lifecycle. Led by CEO Dan Renick, who has over 30 years of experience in the healthcare industry, Petauri aims to enhance clinical and economic value while accelerating the delivery of treatments to patients with unmet medical needs. The company offers a comprehensive range of services, including insights generation, medical and scientific communications, market access, and evidence-based solutions. Its U.S. Market Access activities are divided into three business units: Petauri Advisors, which provides pricing and market access consultancy; Petauri MAx, a strategic payer marketing agency; and Petauri Kinect, which focuses on engagement with health systems and hospitals. Petauri serves pharmaceutical and life sciences clients globally, helping them navigate complex healthcare ecosystems and optimize patient access to innovative therapies.